Drug target and biomarker for multiple sclerosis

— Technology Description

Researchers in Prof. Robyn Klein’s laboratory have discovered that interferon lambda (IFN-λ) is a potential target for treating multiple sclerosis (MS), particularly secondary progressive MS (SPMS).

Most patients with MS present with relapsing remitting MS (RRM…

Neuroactive steroid anesthetic compounds

— Technology Description

Researchers at Washington University have developed a range of steroid anesthetic agents that share known neurosteroid structures but are more potent. These compounds share the basic structure of neurosteroids alphaxalone, allopregnanolone, and ent-androsterone, but the stru…

Create a Collection
Creating...